AREV Life Sciences Global Corp.
AREVF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $3,319 | $9,479 | $4,787 | $2,405 |
| - Cash | $0 | $158 | $298 | $30 |
| + Debt | $29 | $76 | $736 | $573 |
| Enterprise Value | $3,348 | $9,397 | $5,225 | $2,949 |
| Revenue | $49 | $255 | $191 | $195 |
| % Growth | -80.7% | 33.8% | -2.1% | – |
| Gross Profit | $29 | $185 | $191 | $129 |
| % Margin | 59.3% | 72.6% | 100% | 66.3% |
| EBITDA | -$1,311 | -$798 | -$500 | -$3,054 |
| % Margin | -2,668.7% | -312.8% | -262.3% | -1,568.7% |
| Net Income | -$1,444 | -$990 | -$1,049 | -$3,193 |
| % Margin | -2,940.4% | -388.4% | -550.4% | -1,640% |
| EPS Diluted | -0.048 | -0.05 | -0.068 | -0.36 |
| % Growth | 4% | 26.8% | 81% | – |
| Operating Cash Flow | -$284 | -$1,470 | -$24 | -$114 |
| Capital Expenditures | -$82 | -$12 | -$456 | -$215 |
| Free Cash Flow | -$366 | -$1,482 | -$480 | -$329 |